Specialist in Infectious Disease Pathogenesis to Give Purdue Veterinary Conference Diversity Keynote with Pandemic as Backdrop

This year’s Diversity Keynote speaker for the Purdue Veterinary Conference is Dr. Ian Moore, a veterinarian who heads the Infectious Disease Pathogenesis Section at the National Institute of Allergy and Infectious Diseases (NIAID).  A researcher whose collaborative studies include influenza viruses, tuberculosis, coronaviruses (MERS, SARS-CoV-1, SARS-CoV-2), human norovirus, and malaria, Dr. Moore will address diversity issues utilizing insights gained from his role as a scholar involved at the federal level in vaccine development.

Dr. Moore has stated that, “Animal and human health care no longer exist merely as disjointed issues, but are now tethered tightly together by the fabric of One Health with all of the world watching.”  As part of his keynote lecture, Dr. Moore will discuss this reality as it relates to the COVID-19 pandemic exposing what he refers to as “gaping holes in the public health system.“ He explains that those gaping holes relate to the changing roles of veterinarians.  He notes that veterinarians traditionally serviced rural areas and provided general information about animal health and zoonotic diseases.  In contrast, he says veterinarians today have a much broader role in animal and human health, as well as health messaging and communications related to disease surveillance and the emergence of veterinary diseases, particularly those of importance to human health.  His lecture will include insights about the role of veterinary medicine in identifying emerging viruses, developing vaccines and predicting the next pandemic.

Dr. Moore is a native of Brewton, Ala. who earned his Bachelor of Science degree in poultry science and his DVM degree in 2002 and 2006, respectively, at Tuskegee University.  He then began a dual veterinary anatomic pathology residency and PhD program at Michigan State University’s Diagnostic Center for Population and Animal Health in partnership with the National Institutes of Health (NIH).  After completing his three-year residency program and PhD graduate coursework, Dr. Moore transitioned to the NIH where, under the mentorship of Dr. Kanta Subbarao, a world-renowned influenza researcher, he completed his dissertation focused on the pathogenesis and immunology of influenza viruses in animal models. 

After earning his PhD, Dr. Moore was recruited to stay on at NIH and asked to head the Infectious Disease Pathogenesis Section (IDPS) of the NIAID. The IDPS is a molecular pathology research core laboratory that currently supports more than 70 NIH infectious disease investigators, spanning a wide array of infectious disease research projects.  Dr. Moore has co-authored over 50 publications in journals including Nature, The Journal of Infectious Diseases, and the New England Journal of Medicine.  Two of Dr. Moore’s most notable research accomplishments were his identification of the target cell for human norovirus infection and, more recently, his role in performing the pre-clinical safety and efficacy studies for the NIH/Moderna COVID-19 vaccine candidate (mRNA-1273) ahead of human clinical trials and FDA Emergency Use Authorization.

The 2021 Purdue Veterinary Conference will  be held virtually September 7-10, offering four days of high-quality tracks on small animal, equine, food animal, practice management, exotics, and topics of interest for veterinary nurses. Attendees can earn up to 24 hours of continuing education, and will have access to a virtual exhibit hall.

Online registration closes on Tuesday, September 7.  If you miss the online registration deadline, you still will be able to email confreg@purdue.edu to register.

Click here for more information on the conference, including the conference schedule. Click here to register today.

Writer(s): Ben Shepard | pvmnews@purdue.edu

Recent Stories

“Paws Up” – brought to you by the PVM Wellness Committee

This week, we are proud to recognize Lorraine Fox, who is a business assistant with the Veterinary Medicine Procurement Center.

PVM Interview Days Move College Closer to Admitting the DVM Class of 2030

After a total of three afternoons dedicated to conducting in-person interviews with 226 prospective veterinary students, the Purdue University College of Veterinary Medicine is close to completing the process of admitting 84 members of the incoming first-year DVM class – the Class of 2030.  The students invited for the interview days were selected from a total pool of 1,930 applicants from across the country as well as countries abroad.

Experts to Gather at Purdue for Conference Addressing the Public Health Threat of Antimicrobial Resistance

The ongoing challenges posed by multi-drug resistant infections will be the focus of a multidisciplinary conference taking place in three weeks at Purdue University.  The Fourth Annual Conference on Antimicrobial Resistance is set for February 25–26, 2026 at Purdue’s Stewart Center in West Lafayette. Registration is still open for the event, which will bring together scientists and scholars from human and veterinary medicine, public health, research, and industry to address the determinants, dynamics and deterrence of drug resistance.

PVM’s Upcoming Coppoc One Health Lecture to Focus on Dogs as Sentinels of Environmental Exposure

The Purdue University College of Veterinary Medicine brings a leading One Health scholar to campus each year to address vital health issues from a One Health perspective as part of the Coppoc One Health Lecture series.  This year’s presentation, scheduled for February 26 in Lynn Hall Room 2026, is on the engaging topic, “One Health at Home: Dogs as Sentinels of Environmental Exposure.” The speaker will be Audrey Ruple, DVM, MS, PhD, DACVPM, MRCVS, the Dorothy A. and Richard G. Metcalf Professor of Veterinary Medical Informatics at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech.

“Paws Up” – brought to you by the PVM Wellness Committee

Today we are happy to acknowledge our Student Success Center Team.

One Health: A ‘digital twin’ model for predicting cancer outcomes

The striking similarities between invasive bladder cancer in dogs and humans have fueled research advances for more than three decades. Most of that work has looked at separate aspects of the disease — risk factors, early detection, symptoms, treatment and gene expression. But a new project at Purdue University that combines many types of available data in a “digital twin” model of bladder cancer may prove powerful enough to predict patient outcomes, starting with the probability of metastasis.

Purdue Professor Emeritus Bill Blevins Wins Lifetime Achievement Award at ACVR Annual Meeting

The American College of Veterinary Radiology (ACVR) gave its esteemed Lifetime Achievement Award for 2024 to Purdue Professor Emeritus Bill Blevins, who is well known to countless Purdue Veterinary Medicine alumni for the expertise he taught them about all things Diagnostic Imaging during his long Purdue career.